International Urogynecology Journal

, Volume 24, Issue 8, pp 1243–1256 | Cite as

Interstitial cystitis/bladder pain syndrome: diagnosis and management

Review Article

Abstract

Introduction and hypothesis

The bladder pain syndrome (BPS) is a spectrum of urological symptoms characterised by bladder pain with typical cystoscopic features. Diagnosis and management of this syndrome may be difficult. There is no evidence-based management approach for the diagnosis or treatment of BPS. The objective of this study was to critically review and summarise the evidence relating to the diagnosis and treatment of the bladder pain syndrome.

Methods

A review of published data on the diagnosis and treatment of the BPS was performed. Our search was limited to English-language articles, on the “diagnosis”, and “management” or “treatment” of “interstitial cystitis” and the “bladder pain syndrome” in “humans.”

Results

Frequency, urgency and pain on bladder filling are the most common symptoms of BPS. All urodynamic volumes are reduced in patients with BPS. Associated conditions include psychological distress, depression, history of sexual assault, irritable bowel syndrome and fibromyalgia. Cystoscopy remains the test for definitive diagnosis, with visualisation of haemorrhage on cystoreduction. A multidisciplinary treatment approach is essential in the management of this condition. Orally administered amitriptyline is an efficacious medical treatment for BPS. Intravesical hyaluronic acid and local anaesthetic, with/without hydrodistension are among new treatment strategies. Sacral or pudendal neuromodulation is effective, minimally invasive and safe. Surgery is reserved for refractory cases.

Conclusions

There remains a paucity of evidence for the diagnosis and treatment of BPS. We encountered significant heterogeneity in the assessment of symptoms, duration of treatment and follow up of patients in our literature review.

Keywords

Bladder pain syndrome Interstitial cystitis Treatment Management Diagnosis 

Abbreviations

BPS

Bladder pain syndrome

IC

Interstitial cystitis

PBS

Painful bladder syndrome

GP

General practitioner

OAB

Overactive bladder

IBS

Irritable bowel syndrome

QoL

Quality of life

GAG

Glycosaminoglycan

Notes

Acknowledgements

The authors would like to acknowledge Dr Danielle O’Leary and Dr Athanasios Didangelos for their help in the preparation and editing of this manuscript.

Funding for project

There was no funding required for completion of this review.

Conflict of interest

None.

References

  1. 1.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Urology 61(1):37–49PubMedCrossRefGoogle Scholar
  2. 2.
    Hunner GL (1915) A rare type of bladder ulcer in women: report of cases. Boston Med Surg J 172:660–664CrossRefGoogle Scholar
  3. 3.
    Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T et al (2010) Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 29(1):191–198PubMedCrossRefGoogle Scholar
  4. 4.
    Parsons JK, Parsons CL (2004) The historical origins of interstitial cystitis. J Urol 71(1):20–22CrossRefGoogle Scholar
  5. 5.
    Gillenwater JY, Wein AJ (1988) Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, national institutes of health, Bethesda, Maryland. J Urol 140:203–206PubMedGoogle Scholar
  6. 6.
    van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53(1):60–67PubMedCrossRefGoogle Scholar
  7. 7.
    Rovner ES. Interstitial cystitis. Medscape Reference. May 2011. Cited from http://emedicine.medscape.com/article/2055505-overview#a0156
  8. 8.
    Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A (2002) Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 168(1):139–143PubMedCrossRefGoogle Scholar
  9. 9.
    Rosenberg MT, Hazzard M (2005) Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol 174(6):2231–2234PubMedCrossRefGoogle Scholar
  10. 10.
    World Health Organization (1999) 1st International Consultation on Incontinence. Plymbridge Distributors, PlymouthGoogle Scholar
  11. 11.
    Ito T, Ueda T, Honma Y, Takei M (2007) Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int J Urol 14(12):1068–1070PubMedCrossRefGoogle Scholar
  12. 12.
    Clemens JQ, Calhoun EA, Litwin MS, Walker-Corkery E, Markossian T, Kusek JW et al (2010) A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. Urology 76(2):323–328PubMedCrossRefGoogle Scholar
  13. 13.
    Clemens JQ, Joyce GF, Wise M, Payne CK (2007) Interstitial cystitis and painful bladder syndrome. J Urol 177(6):2042–2049PubMedCrossRefGoogle Scholar
  14. 14.
    Pang X, Marchand J, Sant GR, Kream RM, Theorides TC (1995) Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 75(6):744–750PubMedCrossRefGoogle Scholar
  15. 15.
    Harrington DS, Fall M, Johansson SL (1990) Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cystometry analysis. J Urol 144(4):868–871PubMedGoogle Scholar
  16. 16.
    Parsons CL (2007) The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69(4):9–16PubMedCrossRefGoogle Scholar
  17. 17.
    Keay S, Kleinberg M, Zhang CO, Hise MK, Warren JW (2000) Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 164(6):2112–2118PubMedCrossRefGoogle Scholar
  18. 18.
    Patel R, Calhoun EA, Meenan RT, O’Keeffe Rosetti MC, Kimes T, Clemens JQ (2008) Incidence and clinical characteristics of interstitial cystitis in the community. Int Urogynecol J Pelvic Floor Dysfunct 19(8):1093–1096PubMedCrossRefGoogle Scholar
  19. 19.
    Clemens JQ, Bogart LM, Liu K, Pham C, Suttorp M, Berry SH (2011) Perceptions of “urgency” in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurol Urodyn 30(3):402–405CrossRefGoogle Scholar
  20. 20.
    Shorter B, Lesser M, Moldwin RM, Kushner L (2007) Effect of comestibles on symptoms of interstitial cystitis. J Urol 178(1):145–152PubMedCrossRefGoogle Scholar
  21. 21.
    Rackow BW, Novi JM, Arya LA, Pfeifer SM (2009) Interstitial cystitis is an etiology of chronic pelvic pain in young women. J Pediatr Adolesc Gynecol 22(3):181–185PubMedCrossRefGoogle Scholar
  22. 22.
    Warren JW, Langenberg P, Greenberg P, Diggs C, Jacobs S, Wesselmann U (2008) Sites of pain from interstitial cystitis/painful bladder syndrome. J Urol 180(4):1373–1377PubMedCrossRefGoogle Scholar
  23. 23.
    Paulson JD, Paulson JN (2011) Anterior vaginal wall tenderness (AVWT) as a physical symptom in chronic pelvic pain. JSLS 15(1):6–9PubMedCrossRefGoogle Scholar
  24. 24.
    Taneja R (2010) Intravesical lignocaine in the diagnosis of bladder pain syndrome. Int Urogynecol J 21(3):321–324PubMedCrossRefGoogle Scholar
  25. 25.
    Altman D, Lundholm C, Milsom I, Peeker R, Fall M, Iliadou AN et al (2011) The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol 59(2):280–285PubMedCrossRefGoogle Scholar
  26. 26.
    Li GZ, Zhang N, Du P, Yang Y, Wu SL, Xiao YX et al (2010) Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms: a Chinese multi-centre study. Chin Med J 123(20):2842–2846PubMedGoogle Scholar
  27. 27.
    Tettamanti G, Nyman-Illadou A, Pedersen NL, Bellocco R, Milsom I, Altman D (2011) Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology 77(6):1313–1317PubMedCrossRefGoogle Scholar
  28. 28.
    Droz J, Howard FM (2011) Use of the short-form McGill pain questionnaire as a diagnostic tool in women with chronic pelvic pain. J Minim Invasive Gynecol 18(2):211–217PubMedCrossRefGoogle Scholar
  29. 29.
    Nickel JC, Shoskes D, Irvine-Bird K (2009) Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol 182(1):155–160PubMedCrossRefGoogle Scholar
  30. 30.
    Fenton BW, Palmieri PA, Fanning J (2008) Receiver operating characteristic curves of symptom scores in the diagnosis of interstitial cystitis/painful bladder syndrome. J Minim Invasive Gynecol 15(5):601–604PubMedCrossRefGoogle Scholar
  31. 31.
    Kushner L, Moldwin RM (2006) Efficacy of questionnaires used to screen for interstitial cystitis. J Urol 176(2):587–592PubMedCrossRefGoogle Scholar
  32. 32.
    Brewer ME, White WM, Klein FA, Waters WB (2007) Validity of pelvic pain, urgency, and frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome. Urology 70(4):646–649PubMedCrossRefGoogle Scholar
  33. 33.
    Fukui Y, Kato M, Inoue Y, Matsubara A, Itoh K (2009) A metabonomic approach identifies human urinary phenylacetyglutamine as a novel marker of interstitial cystitis. J Chromatogr B Analyt Technol Biomed Life Sci 877(30):3806–3812PubMedCrossRefGoogle Scholar
  34. 34.
    Liu HT, Tyagi P, Chancellor MB, Kuo HC (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 106(11):1681–1685PubMedCrossRefGoogle Scholar
  35. 35.
    Jacobs BL, Smaldone MC, Tyagi V, Philips BJ, Jackman SV, Leng WW et al (2010) Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol 17(1):4989–4994PubMedGoogle Scholar
  36. 36.
    Alp BF, Akyol I, Adayener C, Senkul T, Gultepe M, Baykal K et al (2009) The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome. Int Urol Nephrol 41(3):483–489PubMedCrossRefGoogle Scholar
  37. 37.
    Kuromitsu S, Yokota H, Hiramoto M, Morita S, Mita H, Yamada T (2008) Increased concentration of neutrophil elastase in urine from patients with interstitial cystitis. Scand J Urol Nephrol 42(5):455–461PubMedCrossRefGoogle Scholar
  38. 38.
    Daha LK, Lazar D, Simak R, Pflüger H (2007) Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis? Int Urogynecol J Pelvic Floor Dysfunct 18(12):1449–1452PubMedCrossRefGoogle Scholar
  39. 39.
    Hosseini A, Ehren I, Wiklund NP (2004) Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol 172(6 Pt 1):2261–2265PubMedCrossRefGoogle Scholar
  40. 40.
    Sastry DN, Hunter KM, Whitemore KE (2010) Urodynamic testing and interstitial cystitis/painful bladder syndrome. Int Urogynecol J 21(2):157–161PubMedCrossRefGoogle Scholar
  41. 41.
    Kim SH, Kim TB, Kim SW, Oh SJ (2009) Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. J Urol 181(6):2550–2554PubMedCrossRefGoogle Scholar
  42. 42.
    Sahinkanat T, Guven A, Ekerbicer H, Aral M (2008) Prevalence of positive potassium sensitivity test which is an indicator of bladder epithelial permeability dysfunction in a fixed group of Turkish women. Urol Int 80(1):52–56PubMedCrossRefGoogle Scholar
  43. 43.
    Sairanen J, Tammela TL, Leppilahti M, Onali M, Forsell T, Ruutu M (2007) Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine a and pentosan polysulfate sodium. Neurol Urodyn 26(2):267–270CrossRefGoogle Scholar
  44. 44.
    Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G (1998) The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159(6):186206CrossRefGoogle Scholar
  45. 45.
    Brunstein R, Shapiro E, Kaye J & Moldwin R (2008) The role of cystoscopy in the diagnosis of Hunner’s ulcer disease. J Urol 180(4):1383–1386CrossRefGoogle Scholar
  46. 46.
    Aihara K, Hiayama A, Tanaka N, Fujimoto K, Yoshida K, Hirao Y (2009) Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol 16(12):947–952PubMedCrossRefGoogle Scholar
  47. 47.
    Geurts N, Van Dyck J, Wyndaele JJ (2011) Bladder pain syndrome: do the different morphological and cystoscopic features correlate? Scand J Neurol Urodyn 45(1):20–23CrossRefGoogle Scholar
  48. 48.
    Shie JH, Kuo HC (2011) Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU 108(2):136–141Google Scholar
  49. 49.
    Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE (2008) Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol 179(2):764–769PubMedCrossRefGoogle Scholar
  50. 50.
    Kutlu O, Akkaya E, Koksal IT, Bassorgun IC, Ciftcioglu MA, Sanlioglu S et al (2010) Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis. Int Urol Nephrol 42(2):393–399PubMedCrossRefGoogle Scholar
  51. 51.
    Gamper M, Viereck V, Geissbúhler V, Eberhard J, Binder J, Moll C et al (2009) Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis. BMC Genomics 10:199PubMedCrossRefGoogle Scholar
  52. 52.
    Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP (2008) Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol 180(2):737–741PubMedCrossRefGoogle Scholar
  53. 53.
    Liu HT, Tyagi P, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104(10):1476–1481PubMedCrossRefGoogle Scholar
  54. 54.
    Tseng-Rogenski S, Liebert M (2009) Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol 297(3):816–821CrossRefGoogle Scholar
  55. 55.
    Saban R, Saban MR, Maier J, Fowler B, Tengowski M, Davis CA et al (2008) Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am J Physiol Renal Physiol 295(6):1613–1623CrossRefGoogle Scholar
  56. 56.
    Canter MP, Graham CA, Heit MH, Blackwell LS, Wilkey DW, Klein JB et al (2008) Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects. Am J Obstet Gynecol 198(5):553, e1–e6PubMedCrossRefGoogle Scholar
  57. 57.
    Yamada T, Nishimura M, Mita H (2007) Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients. World J Urol 25(4):407–413PubMedCrossRefGoogle Scholar
  58. 58.
    Zeng Y, Wu XX, Homma Y, Yoshimura N, Iwaki H, Kageyama S et al (2007) Uroplakin III-dlta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis. J Urol 178(4):1322–1327PubMedCrossRefGoogle Scholar
  59. 59.
    Parsons CL, Stein P, Zupkas P, Chenoweth M, Argade SP, Proctor JG et al (2007) Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol 178(6):2665–2670PubMedCrossRefGoogle Scholar
  60. 60.
    Watkins KE, Eberhart N, Hilton L, Suttorp KJ, Hepner KA, Clemens JQ et al (2011) Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample. Gen Hosp Psychiatry 33(2):143–149PubMedCrossRefGoogle Scholar
  61. 61.
    Clemens JQ, Brown SO, Calhoun EA (2008) Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic pelvic pain syndrome: a case study. J Urol 180(4):1378–1382PubMedCrossRefGoogle Scholar
  62. 62.
    Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH (2011) Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis. Urology 77(3):576–580PubMedCrossRefGoogle Scholar
  63. 63.
    Peters KM, Killinger KA, Carrico DJ, Ibrahim IA, Diokno AC, Graziottin A (2007) Sexual function and sexual distress in women with interstitial cystitis: a case–control study. Urology 70(3):543–547PubMedCrossRefGoogle Scholar
  64. 64.
    Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR et al (2010) Childhood maltreatment and migraines (part III). Association with comorbid pain conditions. Headache 50(1):42–51PubMedCrossRefGoogle Scholar
  65. 65.
    Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes TA, Calhoun EA (2008) Case–control study of medical comorbidities in women with interstitial cystitis. J Urol 179(6):2222–2225PubMedCrossRefGoogle Scholar
  66. 66.
    Bassaly R, Tidwell N, Bertolino S, Hoyte L, Downes K, Hart S (2011) Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J 22(4):413–418PubMedCrossRefGoogle Scholar
  67. 67.
    Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK et al (2010) Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 184(4):1358–1363PubMedCrossRefGoogle Scholar
  68. 68.
    Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC (2007) Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 70(1):16–18PubMedCrossRefGoogle Scholar
  69. 69.
    Nickel JC, Tripp D, Teal V, Propert KJ, Burks D, Foster HE et al (2007) Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol 177(5):1832–1836PubMedCrossRefGoogle Scholar
  70. 70.
    Ginting JV, Tripp DA, Nickel JC, Fitzgerald MP, Mayer R (2011) Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome. BJU Int 108(5):713–717PubMedGoogle Scholar
  71. 71.
    El Khoudary SR, Talbott EO, Bromberger JT, Chang CC, Songer TJ, Davis EL (2009) Severity of interstitial cystitis symptoms and quality of life in female patients. J Women Health (Larchmt) 18(9):1361–1368CrossRefGoogle Scholar
  72. 72.
    Ingber MS, Peters KM, Killinger KA, Carrico DJ, Ibrahim IA, Diokno AC (2008) Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 19(3):341–345PubMedCrossRefGoogle Scholar
  73. 73.
    Stanford E, McMurphy C (2007) There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct 18(5):551–554PubMedCrossRefGoogle Scholar
  74. 74.
    Abrahms P, Cardozo L, Khoury S, Wein A. Incontinence. 4th Edition 2009. 4th International Consultation on Incontinence. July 2008.Google Scholar
  75. 75.
    Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald P et al (2011) Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. American Urological Association (AUA). J Urol 185(6):2162–2170PubMedCrossRefGoogle Scholar
  76. 76.
    Carrico DJ, Peters KM, Diokno AC (2008) Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J Altern Complement Med 14(1):53–60PubMedCrossRefGoogle Scholar
  77. 77.
    Hertle L, van Ophoven A (2010) Long-term results of amitriptyline treatment for interstitial cystitis. Aktuelle Urol 41 [Suppl 1]:S61–S65PubMedCrossRefGoogle Scholar
  78. 78.
    Lee JW, Han DY, Jeong HJ (2010) Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a non-steroidal anti-inflammatory drug. Int Neurourol J 14(4):256–260PubMedCrossRefGoogle Scholar
  79. 79.
    Seshadri P, Emerson L, Morales A (1994) Cimetidine in the treatment of interstitial cystitis. Urology 44(4):614–616PubMedCrossRefGoogle Scholar
  80. 80.
    Daha LK, Lazar D, Simak R, Pfluger H (2008) The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results. Int Urogynecol J Pelvic Floor Dysfunct 19(7):987–990PubMedCrossRefGoogle Scholar
  81. 81.
    Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ (2008) Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179(1):177–185PubMedCrossRefGoogle Scholar
  82. 82.
    Engelhardt PF, Morakis N, Daha LK, Esterbauer B, Riedl CR (2011) Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J 22(4):401–405PubMedCrossRefGoogle Scholar
  83. 83.
    Cervigni M, Natale F, Nasta L, Padoa A, Voi RL, Porru D (2008) A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 19(7):943–947PubMedCrossRefGoogle Scholar
  84. 84.
    Nickel JC, Hanno P, Kumar K, Thomas H (2012) Second multicenter, randomized, double-blind parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 79(6):1220–1224PubMedCrossRefGoogle Scholar
  85. 85.
    Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type a injections plus hydrodistension with hydrodistension alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 104(5):657–661PubMedCrossRefGoogle Scholar
  86. 86.
    Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG (2009) Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 103(7):910–918PubMedCrossRefGoogle Scholar
  87. 87.
    Cox M, Klutke JJ, Klutke CG (2009) Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol 16(2):4536–4540PubMedGoogle Scholar
  88. 88.
    Chuang YC, Lee WC, Lee WC, Chiang PH (2009) Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol 182(4):1393–1400PubMedCrossRefGoogle Scholar
  89. 89.
    Stav K, Beberashvili I, Lindner A, Leibovici D (2012) Predictors of response to intravesical-sulfoxide cocktail in patients with interstitial cystitis. Urology 80(1):61–65PubMedCrossRefGoogle Scholar
  90. 90.
    Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V et al (2008) Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol 179(2):552–555PubMedCrossRefGoogle Scholar
  91. 91.
    Peng CH, Kuo HC (2007) Multiple intravesical instillations of low dose resiniferatoxin in the treatment of refractory interstitial cystitis. Urol Int 78(1):78–81PubMedCrossRefGoogle Scholar
  92. 92.
    Barbalias GA, Liatsikos EN, Athanasopoulos A, Nikiforidis G (2000) Interstitial cystitis: bladder training with intravesical oxybutynin. J Urol 163(6):1818–1822PubMedCrossRefGoogle Scholar
  93. 93.
    Tanaka T, Nitta Y, Morimoto K, Nishikawa N, Nishihara C, Tamada S et al (2011) Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan. BMC Urol 24:11CrossRefGoogle Scholar
  94. 94.
    Sairanen J, Tammela TL, Leppilahti M, Multanen M, Paananen I, Lehtoranta K et al (2005) Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 174(6):2235–2238PubMedCrossRefGoogle Scholar
  95. 95.
    Hsieh CH, Chang ST, Hsieh CJ, Hsu CS, Chang HC, Lin YH (2008) Treatment of interstitial cystitis with hydrodistension and bladder training. Int Urogynecol J Pelvic Floor Dysfunct 19(10):1379–1384PubMedCrossRefGoogle Scholar
  96. 96.
    Ghazwani YQ, Elkelini MS, Hassouna MM (2011) Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow up. Neurourol Urodyn 30(7):1271–1275PubMedGoogle Scholar
  97. 97.
    Gajewski JB, Al-Zahrani AA (2011) The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int 107(8):1258–1264PubMedCrossRefGoogle Scholar
  98. 98.
    Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV (2008) Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct 19(4):553–557PubMedCrossRefGoogle Scholar
  99. 99.
    Peters KM, Feber KM, Bennett RC (2007) A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int 100(4):835–839PubMedCrossRefGoogle Scholar
  100. 100.
    O’Reilly BA, Dwyer PL, Hawthorne G, Cleaver S, Thomas E, Rosmilia A et al (2004) Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis. J Urol 172(5 Pt 1):1880–1883PubMedCrossRefGoogle Scholar
  101. 101.
    Kochakarn W, Lertsithichai P, Pummangura W (2007) Bladder substitution by ileal neobladder for women with interstitial cystitis. Int Braz J Urol 33(4):486–492PubMedCrossRefGoogle Scholar
  102. 102.
    Rössberger J, Fall M, Jonsson O, Peeker R (2007) Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: sub-typing is imperative. Urology 70(4):638–642PubMedCrossRefGoogle Scholar

Copyright information

© The International Urogynecological Association 2013

Authors and Affiliations

  1. 1.Department of UrogynaecologyCork University Maternity HospitalWiltonIreland
  2. 2.Neurorestoration Group, Wolfson CARDKing’s College LondonLondonUK

Personalised recommendations